Ignacio Plaza

926 total citations
48 papers, 531 citations indexed

About

Ignacio Plaza is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ignacio Plaza has authored 48 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ignacio Plaza's work include Cardiac Valve Diseases and Treatments (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Infective Endocarditis Diagnosis and Management (7 papers). Ignacio Plaza is often cited by papers focused on Cardiac Valve Diseases and Treatments (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Infective Endocarditis Diagnosis and Management (7 papers). Ignacio Plaza collaborates with scholars based in Spain, Sweden and Argentina. Ignacio Plaza's co-authors include José A. Casasnovas, José A. Velasco, Javier Muñiz, Juan Cosín, Morris Villarroel, Bettina König, András Bittsánszky, Ranka Junge, Tamás Kőmíves and Luís Felipe Pallardo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Ignacio Plaza

44 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Plaza Spain 12 227 151 113 70 69 48 531
Mina Hayama‐Terada Japan 12 123 0.5× 45 0.3× 34 0.3× 72 1.0× 10 0.1× 43 367
Pengkun Song China 14 33 0.1× 126 0.8× 65 0.6× 90 1.3× 26 0.4× 52 783
Suphi Vehid Türkiye 14 63 0.3× 41 0.3× 50 0.4× 38 0.5× 4 0.1× 38 453
Tomoko Shimakawa United States 14 117 0.5× 112 0.7× 132 1.2× 72 1.0× 2 0.0× 20 861
Y Naito Japan 7 137 0.6× 98 0.6× 168 1.5× 113 1.6× 4 0.1× 15 396
Rose Ga United Kingdom 10 177 0.8× 91 0.6× 34 0.3× 21 0.3× 3 0.0× 18 661
Yoshimi Kubota Japan 11 52 0.2× 43 0.3× 24 0.2× 30 0.4× 15 0.2× 28 368
Amber Fatima United States 9 508 2.2× 163 1.1× 41 0.4× 64 0.9× 5 0.1× 24 681
Toru Kuribayashi Japan 13 164 0.7× 55 0.4× 61 0.5× 63 0.9× 37 497
Mauri M. Hämäläinen Finland 13 114 0.5× 31 0.2× 37 0.3× 24 0.3× 4 0.1× 25 518

Countries citing papers authored by Ignacio Plaza

Since Specialization
Citations

This map shows the geographic impact of Ignacio Plaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Plaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Plaza more than expected).

Fields of papers citing papers by Ignacio Plaza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Plaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Plaza. The network helps show where Ignacio Plaza may publish in the future.

Co-authorship network of co-authors of Ignacio Plaza

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Plaza. A scholar is included among the top collaborators of Ignacio Plaza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Plaza. Ignacio Plaza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Juanatey, Carlos, Manuel Anguita‐Sánchez, Vivencio Barrios, et al.. (2022). Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. Journal of Clinical Medicine. 11(20). 6004–6004. 8 indexed citations
2.
Jurado‐Román, Alfonso, Guillermo Galeote, Laura Rodríguez, et al.. (2019). TCT-725 Comparative Study of the Hemodynamic Performance of Two Latest Generation Supra-Annular Self-Expanding Transcatheter Aortic Valves (Allegra Versus ACURATE neo). Journal of the American College of Cardiology. 74(13). B711–B711. 1 indexed citations
3.
Plaza, Ignacio, et al.. (2019). Effect ofArthrospirasupplementation onOreochromis niloticusgut microbiota and flesh quality. Aquaculture Research. 50(5). 1448–1458. 10 indexed citations
4.
Salinas, Pablo, Raúl Moreno, Luís Calvo, et al.. (2015). Long-term Follow-up After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. Revista Española de Cardiología (English Edition). 69(1). 37–44. 10 indexed citations
5.
Salinas, Pablo, Raúl Moreno, Sergio García‐Blas, et al.. (2015). Prognostic impact of decisions taken by the heart team in patients evaluated for transcatheter aortic valve implantation. Revista Portuguesa de Cardiologia. 34(10). 587–595. 3 indexed citations
6.
Moreno, Raúl, Santiago Jiménez‐Valero, Ángel Sánchez‐Recalde, et al.. (2011). Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents. EuroIntervention. 6(8). 1003–1010. 9 indexed citations
7.
Salinas, Pablo, Guillermo Galeote, Roberto Martín-Reyes, et al.. (2011). Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry. EuroIntervention. 6(9). 1080–1084. 18 indexed citations
8.
Moreno, Raúl, David Filgueiras‐Rama, Luís Calvo, et al.. (2009). Implantación de prótesis valvulares aórticas por vía transfemoral. Evaluación de pacientes candidatos al procedimiento. Medicina Clínica. 133(11). 414–421. 7 indexed citations
9.
Moreno, Raúl, Roberto Martín-Reyes, Santiago Jiménez‐Valero, et al.. (2009). Determining clinical benefits of drug-eluting coronary stents according to the population risk profile: A meta-regression from 31 randomized trials. International Journal of Cardiology. 148(1). 23–29. 3 indexed citations
10.
Eyjolfsson, Atli, et al.. (2009). Cardiorespiratory effects of venous lipid micro embolization in an experimental model of mediastinal shed blood reinfusion. Journal of Cardiothoracic Surgery. 4(1). 48–48. 6 indexed citations
11.
Dencker, Magnus, et al.. (2008). The kinetics of lipid micro-emboli during cardiac surgery studied in a porcine model. Scandinavian Cardiovascular Journal. 42(6). 411–416. 6 indexed citations
12.
Ascaso, Juan F., Antonio Hernández Mijares, Alipio Mangas, et al.. (2007). Management of Dyslipidemia in the Metabolic Syndrome. American Journal of Cardiovascular Drugs. 7(1). 39–58. 50 indexed citations
13.
Ascaso, J.F., Pedro González‐Santos, Antonio Hernández Mijares, et al.. (2006). Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio. Recomendaciones del foro HDL. Resumen ejecutivo. Revista Clínica Española. 206(11). 576–582. 6 indexed citations
14.
Ascaso, Juan F., et al.. (2004). Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention. American Journal of Cardiovascular Drugs. 4(5). 299–314. 27 indexed citations
15.
Velasco, José A., et al.. (2000). [Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation].. PubMed. 53(8). 1095–120. 56 indexed citations
16.
Couch, Sarah C., Kaichi Kida, Emilio Ros, et al.. (2000). Rapid westernization of children’s blood cholesterol in 3 countries: evidence for nutrient-gene interactions?. American Journal of Clinical Nutrition. 72(5). 1266s–1274s. 35 indexed citations
17.
Serena, Joaquı́n, et al.. (1999). [Normal values for transcranial doppler studies in our medium].. PubMed. 14(9). 437–43. 7 indexed citations
18.
Plaza, Ignacio, et al.. (1990). [The Fuenlabrada study: relationship between anthropometric variables and cardiovascular risk factors].. PubMed. 43(3). 282–299. 1 indexed citations
19.
Plaza, Ignacio, et al.. (1990). [Fuenlabrada study: lipid and lipoprotein levels in children and adolescents associated with ischemic cardiopathy prevalence among their relatives].. PubMed. 43(4). 212–8. 3 indexed citations
20.
Plaza, Ignacio, et al.. (1989). [The Fuenlabrada study: lipids and lipoproteins in children and adolescents].. PubMed. 42(7). 444–58. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mina Hayama‐Terada Breakdown of academic impact, for papers by Pengkun Song Breakdown of academic impact, for papers by Suphi Vehid Breakdown of academic impact, for papers by Tomoko Shimakawa Breakdown of academic impact, for papers by Y Naito Breakdown of academic impact, for papers by Rose Ga Breakdown of academic impact, for papers by Yoshimi Kubota Breakdown of academic impact, for papers by Amber Fatima Breakdown of academic impact, for papers by Toru Kuribayashi Breakdown of academic impact, for papers by Mauri M. Hämäläinen
Rankless by CCL
2026